switching from retatrutide to tirzepatide retatrutide: the complete transition guide How Is Retatrutide Compared to

Thus, in patients with type 2 diabetes, combination incretin therapy is poised to provide better glycemic efficacy than treatment with a GLP-1 receptor agonist alone while maintaining a good side-effect profile with respect to avoiding hypoglycemia. As Healio previously reported, top-line data from SURPASS-4, the largest and longest trial of the program to date, also demonstrated that tirzepatide significantly reduced HbA1c and body weight compared with insulin glargine (Lantus, Sanofi) for adults with type 2 diabetes at high cardiovascular risk

Lab work is rarely required, check-ins are limited, and compounded medications make up much of the offering

One recent study tested the effect of semaglutide on the heart health of non-diabetic subjects

Laurie Sund, medical director for the Medical Weight Management Clinic at MHealth Fairview